NIH | National Cancer Institute | NCI Wiki  

Date

Attendees

Committee MemberPresentAbsent
X
X

X

X
Elaine Ostrander
X
Deborah KnappX
Jeff Trent
X
Dawn DuvalX
Amy LeblancX
Heather Gardner
X
Cheryl LondonX
Christina Mazcko
X
Paula Jacobs
X
Renee Chambers
X
Shaying Zhao

X


Sunetra Das
X

Outstanding Action Items


  • Toby to reach out to Connie about extending invite to new PRECINCT members.
  • Cheryl London to write abstract and also update the paper to include the new
  • Cheryl London to add acknowledgement sections to the manuscripts.

Agenda

Agenda ItemWhoNotes
BPSC Review Article: Tools & Resources for the Canine Genomic LandscapeGroup Discussion
  • Submitted to Veterinary and Comparative Oncology on May 6, 2023
    • "Leading the Pack: Best Practices in Comparative Canine Cancer Genomics to Inform Human Oncology"
    • Insert link to final version here


Meeting Minutes (Not Verbatim)

TH - Let's think about repurposing this committee or augmenting the scope of this committee

CL - Issues with integrity of RNA and frozen specimens just as an example, perhaps protocol and data analysis standardizations.

AL - Beginning with nucleic acid extraction, dependent on tissue type, getting a single nuclei out of a real bone tumor, easy to do in mouse and simple tissues, but there are not standard protocols in dog.

TH - Would there be a place in the ICDC for SOPs pertaining to RNA isolation, nucleic acid extraction, library preparation, sequencing methods?

TH - Highlighting differences between human and dog, maybe differences in assay prep could contribute to differences in data

HG - Moving away from bulk RNA-Seq and whole exome, instead working with liquid biopsy and microRNA-Seq. It would be nice to have a community that has been working in parallel on some of these things, obtaining samples and QC of samples, library prep, and data analysis (no input on the canine side since most tools are developed for human).

AL - Methylation is a good example, doing this in Osteo right now, low pass whole genome helps to interpret methylation results computationally, this was something that was not known initially.

CL - A roadmap for people that don't always work with canine samples would be helpful so that they are not discouraged.

HG - Availability of analysis pipelines even for working locally.

SZ - Some discussion around canFam4 and annotation

AL - Sample procurement and processing is a good place to start as well as the buckets for analysis mentioned by Heather.

DD - There is talk of a Pan canFam genome 

SZ - Genome annotation cannot be done by a single lab, this needs to be a community effort

CL - We can start with simple things such as sample requisition and sample preservation, OCT blocks cannot be used because the RNA is degraded.

HG - Challenges are around RNA quality and it is not high enough to perform 10X spatial transcriptomics. My understanding is that NCBI was going to handle annotations for canFam4, but instead they did the ROS version of the genome instead.

TH - Elaine may be a good contact for reaching out to NCBI

AL - We gained a ton of experience with NanoString from FFPE and how to approach these type of samples for the canine IO profiling assay, garbage in garbage out.

HG - QC has changed for the nCounter

AL - Having a pathologist involved is very important when assessing the integrity of samples, it is no longer RIN

Contacts from Dawn Duval regarding canFam4

Kerstin Lindblad-toh gave me these indivivduals as potential contacts to pressure for annotation of the GSD genome.ENSEMBLE

fergal@ebi.ac.uk

rd109@cam.ac.uk

NCBI

thibaudf@ncbi.nlm.nih.gov


Action items

  • Kuffel, Gina (NIH/NCI) [C] to start 2 docs, 1 for items to tack for standardization, 1 for the letter to move the needle on canFam4 annotations.